We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational reality – providing the best opportunity to make a dramatic difference in patients’ lives. THE THIRD ROCK TEAMOur team has a proven record of translating disruptive technologies into valuable business enterprises. Working closely with leading scientific and business visionaries as well as industry partners, we identify opportunities to change the future of medicine and rigorously vet those ideas through our discovery process to develop the vision, strategy and plan needed to succeed. A FORMULA FOR INNOVATION We only invest in the best of those ideas. We are actively involved in the early stages of our companies’ development, typically serving as members of the founding management teams, to build a strong foundation, put in place the right people and culture, and set the companies on a path to scientific and operational excellence.We believe in the companies we launch and make big initial investments, often complemented by strategic alliances, to enable our companies to advance life-changing therapies, devices and diagnostics. By creating value for patients, we create value for our investors.

Global Blood Therapeutics

Voyager Therapeutics

Larimar Therapeutics

Revolution Medicines

Rhythm Pharmaceuticals

SAGE Therapeutics

Bluebird Bio

Kala Pharmaceuticals

Nurix Therapeutics

Blueprint Medicines

Tango Therapeutics

Magenta Therapeutics

Thrive Earlier Detection

Constellation Pharmaceuticals

CytomX Therapeutics

Editas Medicine

Foundation Medicine

Fulcrum Therapeutics

Pliant Therapeutics

Relay Therapeutics

Third Rock Ventures

Companies with products for Alzheimer's, ALS, Parkinson's, and Huntington's in the final stages of clinical testing.

BioSpace Late-Stage Contenders

Uplinza (inebilizumab-cdon) and Enspryng (satralizumab-mwge) were approved in 2020 for neurodegenerative diseases.

FDA-Approved Therapies

Focused on finding therapies to cure or halt the progression of dementia and related diseases.

Center for Alzheimer's and Neurodegenerative Diseases at UT Southwestern

MareaTX is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases. The company leverages a proprietary drug discovery platform to identify and advance novel therapeutic candidates for conditions such as Alzheimer's disease.

MareaTX

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 5:06 PM	5a735d28
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 9:17 PM	07e26ef9
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 22, 2024 5:06 PM	b7de4081
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 5:06 PM	829b6ecb
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MAREATX

MareaTX